Viewing Study NCT02240056


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-02-19 @ 6:53 PM
Study NCT ID: NCT02240056
Status: COMPLETED
Last Update Posted: 2019-03-07
First Post: 2014-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brain fMRT In Takotsubo Cardiomyopathy
Sponsor: Wolfgang Dichtl, MD PhD
Organization:

Study Overview

Official Title: Pilot Study: Central Nervous System and Hormonal Changes In Takotsubo Cardiomyopathy
Status: COMPLETED
Status Verified Date: 2019-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TAKINSULA
Brief Summary: Certain cardiac and neurologic diseases influence each other via a still poorly understood "brain-heart axis". Subarachnoidal bleedings are well known to cause ECG alterations resembling those of myocardial infarction, along with a reduction of systolic myocardial function ("neurogenic stunned myocardium"). Alterations of the right insula region by a stroke or intracranial hemorrhage go along with a sympathetic activation (increased circulating catecholamine levels, tachycardia, arterial hypertension). In contrast, alterations of the left insula region often cause vagal reactions such as bradycardia, arterial hypotension. Takotsubo cardiomyopathy (TTC) is a just recently recognised subform of heart attacks, often caused by psychological or physical stress (death of a beloved one, divorce, job loss, infection, preoperative state). In more than 90% of cases, TTC affects postmenopausal women.

Functional MRT enables imaging of activated brain regions, either without ("resting state") or with specific stimuli. The investigators speculate that there is a specific involvement of the insula region during TTC.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: